Boston Scientific Corp.

NYSE:BSX

50.03

+0.43 (+0.87%)

7:47:10 PM EDT: $49.85 -0.18 (-0.36%)

Divestitures / Spin-offs, Mergers / Acquisitions

Boston Scientific Signs Definitive Agreement To Divest Btg Specialty Pharmaceuticals Business

Published: 12/01/2020 12:37 GMT

Boston Scientific Corp. (BSX) - Boston Scientific Signs Definitive Agreement to Divest Btg Specialty Pharmaceuticals Business.
Boston Scientific Corp - Deal for $800 Million in Cash.
Boston Scientific Corp - Deal Includes Transfer of Five Facilities and Approximately 280 Employees Globally.